Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Suzette, Oelofse"'
Autor:
Alex John Scott, Mohammed Limbada, Tahlia Perumal, Shameem Jaumdally, Andrea Kotze, Charnay van der Merwe, Maina Cheeba, Deborah Milimo, Keelin Murphy, Bram van Ginneken, Mariana de Kock, Robin Mark Warren, Phindile Gina, Jeremi Swanepoel, Louié Kühn, Suzette Oelofse, Anil Pooran, Aliasgar Esmail, Helen Ayles, Keertan Dheda
Publikováno v:
International Journal of Infectious Diseases, Vol 145, Iss , Pp 107081- (2024)
Objectives: To evaluate diagnostic yield and feasibility of integrating testing for TB and COVID-19 using molecular and radiological screening tools during community-based active case-finding (ACF). Methods: Community-based participants with presumed
Externí odkaz:
https://doaj.org/article/0923d8138f7946fd86e1ae2a08c1947d
Autor:
Gregory L. Calligaro, Nevadna Singh, Timothy C. Pennel, Rachelle Steyn, Anita Brink, Aliasgar Esmail, Lynelle Mottay, Suzette Oelofse, Barbara L. Mastrapa, Wisdom Basera, Kathryn Manning, Chima Ofoegbu, Anthony Linegar, Keertan Dheda
Publikováno v:
EClinicalMedicine, Vol 55, Iss , Pp 101728- (2023)
Summary: Background: Surgery remains an adjunctive treatment for drug-resistant tuberculosis (DR-TB) treatment failure despite the use of bedaquiline. However, there are few data about the role of surgery when combined with newer drugs. There are no
Externí odkaz:
https://doaj.org/article/4331e76699fa41338213b4f9b480600e
Autor:
Jana Daher, Nora Engel, Aliasgar Esmail, Suzette Oelofse, Megan Smallwood, Gayatri Marathe, Nicolaos Karatzas, Keertan Dheda, Nitika Pai, Paramita Saha Chaudhuri, Marietjie Pretorius, Mohammed Fadul, Anna de Waal, Alice Anne Zwerling
Publikováno v:
BMJ Global Health, Vol 6, Iss 9 (2021)
Introduction Implementation data for digital unsupervised HIV self-testing (HIVST) are sparse. We evaluated the impact of an app-based, personalised, oral HIVST program offered by healthcare workers in Western Cape, South Africa.Methods In a quasiran
Externí odkaz:
https://doaj.org/article/a3c1f04fbf52487390dbf04db04f5602
Autor:
Tobias Broger, Lisa Koeppel, Helena Huerga, Poppy Miller, Ankur Gupta-Wright, François-Xavier Blanc, Aliasgar Esmail, Byron W P Reeve, Marco Floridia, Andrew D Kerkhoff, Fausto Ciccacci, Margaret P Kasaro, Swe Swe Thit, Mathieu Bastard, Gabriella Ferlazzo, Christina Yoon, Daniël J Van Hoving, Bianca Sossen, Juan Ignacio García, Matthew J Cummings, Rachel M Wake, Josh Hanson, Adithya Cattamanchi, Graeme Meintjes, Gary Maartens, Robin Wood, Grant Theron, Keertan Dheda, Ioana Diana Olaru, Claudia M Denkinger, Suzette Oelofse, Didier Laureillard, Mauro Andreotti, Obvious Nchimunya Chilyabanyama, Benjamin Welu, Lucas Molfino, Sekai Chenai Mathabire Rücker, Elisabeth Szumilin, Loide Cossa, Johanna Meléndez, Linda Mbuthini, Max O'Donnell, Joseph N Jarvis, Gcobisa Ndlangalavu, Katherine Fielding
Publikováno v:
The Lancet Global Health. 11:e903-e916
Autor:
Aliasgar Esmail, Philippa Randall, Suzette Oelofse, Michele Tomasicchio, Anil Pooran, Richard Meldau, Edson Makambwa, Lynelle Mottay, Shameem Jaumdally, Gregory Calligaro, Stuart Meier, Marianna de Kock, Tawanda Gumbo, Robin Mark Warren, Keertan Dheda
Publikováno v:
Nature Medicine. 29:1009-1016
Autor:
Aliasgar Esmail, Suzette Oelofse, Carl Lombard, Rubeshan Perumal, Linda Mbuthini, Akhter Goolam Mahomed, Ebrahim Variava, John Black, Patrick Oluboyo, Nelile Gwentshu, Eric Ngam, Tertius Ackerman, Linde Marais, Lynelle Mottay, Stuart Meier, Anil Pooran, Michele Tomasicchio, Julian Te Riele, Brigitta Derendinger, Norbert Ndjeka, Gary Maartens, Robin Warren, Neil Martinson, Keertan Dheda
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 205:1214-1227
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts
Autor:
Francesca Conradie, G Wills, M. Olugbosi, A Calatroni, Mendel Carl M, Pauline Howell, Daniel Everitt, E Sun, N Ngubane, Aliasgar Esmail, A. del Parigi, Angela M. Crook, Melvin Spigelman, Andreas H. Diacon, Olatunde Olayanju, Keertan Dheda, Suzette Oelofse
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 25:453-460
BACKGROUND: There are no data comparing the 6–9 month oral three-drug Nix regimen (bedaquiline, pretomanid and linezolid [BPaL]) to conventional regimens containing bedaquiline (B, BDQ) and linezolid (L, LZD).METHODS: Six-month post end-of-treatmen
Autor:
Shabir A, Madhi, Vicky, Baillie, Clare L, Cutland, Merryn, Voysey, Anthonet L, Koen, Lee, Fairlie, Sherman D, Padayachee, Keertan, Dheda, Shaun L, Barnabas, Qasim E, Bhorat, Carmen, Briner, Gaurav, Kwatra, Khatija, Ahmed, Parvinder, Aley, Sutika, Bhikha, Jinal N, Bhiman, As'ad E, Bhorat, Jeanine, du Plessis, Aliasgar, Esmail, Marisa, Groenewald, Elizea, Horne, Shi-Hsia, Hwa, Aylin, Jose, Teresa, Lambe, Matt, Laubscher, Mookho, Malahleha, Masebole, Masenya, Mduduzi, Masilela, Shakeel, McKenzie, Kgaogelo, Molapo, Andrew, Moultrie, Suzette, Oelofse, Faeezah, Patel, Sureshnee, Pillay, Sarah, Rhead, Hylton, Rodel, Lindie, Rossouw, Carol, Taoushanis, Houriiyah, Tegally, Asha, Thombrayil, Samuel, van Eck, Constantinos K, Wibmer, Nicholas M, Durham, Elizabeth J, Kelly, Tonya L, Villafana, Sarah, Gilbert, Andrew J, Pollard, Tulio, de Oliveira, Penny L, Moore, Alex, Sigal, Alane, Izu, Peter, Zuidewind
Publikováno v:
The New England Journal of Medicine : NEJM / Publ. by the Massachusetts Medical Society
Background Assessment of the safety and efficacy of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is investigation of the efficacy of the vaccines against emerging SARS-CoV
Autor:
Anthonet L. Koen, Alane Izu, Vicky Baillie, Gaurav Kwatra, Clare L. Cutland, Lee Fairlie, Sherman D. Padayachee, Keertan Dheda, Shaun L. Barnabas, Qasim Ebrahim Bhorat, Carmen Briner, Khatija Ahmed, Sutika Bhikha, Jinal N. Bhiman, Jeanine du Plessis, Aliasgar Esmail, Elizea Horne, Shi-Hsia Hwa, Aylin Oommen-Jose, Teresa Lambe, Matt Laubscher, Mookho Malahleha, Gabriella Benade, Shakeel McKenzie, Suzette Oelofse, Faeezah Patel, Sureshnee Pillay, Sarah Rhead, Hylton Rodel, Carol Taoushanis, Houriiyah Tegally, Asha Thombrayil, Tonya L. Villafana, Sarah Gilbert, Andrew J. Pollard, Shabir A. Madhi
In this South African phase 1/2b study, we demonstrated vaccine efficacy (VE) of two doses of AZD1222 for asymptomatic and symptomatic SARS-CoV-2 infection: 90.6% against wild-type and 77.1% against the Delta variant ≥9 months after vaccination. VE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90f5a6d20644392d1f0fb82c06d8b6c8
https://doi.org/10.1101/2022.07.18.22277743
https://doi.org/10.1101/2022.07.18.22277743
Autor:
Shabir A. Madhi, Gaurav Kwatra, Richard Welch, Anthonet L. Koen, Vicky L. Baillie, Clare Cutland, Lee Fairlie, Sherman D. Padayachee, Keertan Dheda, Shaun L. Barnabas, Qasim Ebrahim Bhorat, Carmen Briner, Khatija Ahmed, Parvinder K. Aley, Sutika Bhikha, As'ad Ebrahim Bhorat, Aliasgar Esmail, Elizea Horne, Haajira Kaldine, Christian K. Mukendi, Vimbai Sharon Madzorera, Nelia P. Manamela, Mduduzi Masilela, Tandile Hermanus, Thopisang Motlou, Nonkululeko Mzindle, Suzette Oelofse, Faeezah Patel, Sarah Rhead, Lindie Rossouw, Carol Taoushanis, Samuel van Eck, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard, Penny L. Moore, Alane Izu
Publikováno v:
SSRN Electronic Journal.